These results suggest that RG and fRG can alleviate allergic rhinitis in mice by suppressing IgE, IL-4, IL-5, and IL-13 expression and restoring altered gut microbiota and that fRG may display anti-allergic rhinitis activity more strongly than RG did due to the richness of absorbable ginsenosides. The gene discussed is IL13; the disease is allergic rhinitis.